跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 127 条关于
“HKEX”
全部
127
临床试验
2
药物
12
机构
56
资讯
57
5个月前
Kelun-Biotech Achieves HKEX Milestone with "B" Marker Removal, Advances Global ADC Pipeline
上个月
Axiom Biosciences Plans Landmark Hong Kong IPO, Becoming First U.S. Biotech to List on HKEX
2个月前
Jingze Bio Files Third HKEX IPO Application, Spotlighting Biosimilar Competition in China's Fertility and Ophthalmology Markets
3个月前
Hong Kong Chamber Urges Removal of 'Novelty Test' to Ease Listing Rules for Biotech and Innovative Companies
去年
Hengrui Pharmaceuticals Aims to Raise $1.27 Billion in Hong Kong IPO
上个月
Sino Biopharmaceutical Unveils Global Brand SBP Group to Accelerate International Expansion
上个月
CSPC's HA1406 Hits Primary Endpoint in Phase III Depression Trial
2个月前
Alebund Pharmaceuticals Debuts on Hong Kong Stock Exchange, Raising $164 Million to Advance Broad Renal Pipeline
去年
Singapore Biotech Mirxes Achieves $1 Billion Valuation with Hong Kong IPO, Becomes First Southeast Asian Unicorn
上个月
Transcenta Sells Hangzhou CDMO Plant to WuXi Biologics for RMB 190 Million, Then Licenses HiCB Platform Back to the Buyer
第 1 页,共 6 页
上一页
下一页